Article

Formal thought disorder in non-clinical individuals with auditory verbal hallucinations.

The Neuroscience Division University Medical Center Utrecht, Rudolf Magnus School for Neuroscience, Netherlands.
Biological Psychiatry (impact factor: 8.28). 02/2010; 118(1-3):140-5. DOI:10.1016/j.schres.2010.01.024 pp.140-5
Source: PubMed

ABSTRACT Auditory verbal hallucinations (AVH) and formal thought disorder (FTD) may originate from the same aberration in the language system. The hypothesis of a shared neurobiological basis would be strengthened by the presence of FTD in individuals who frequently experience AVH, but do not meet DSM-IV criteria for a psychotic disorder.
In this study, FTD was quantified in 40 non-clinical subjects with AVH, in 50 healthy subjects without AVH and in 40 schizophrenia patients with AVH. Recorded speech samples were analysed by one rater who was blind to the presence/absence of AVH and to diagnosis, using the Thought and Language Index.
Negative FTD was barely present in non-clinical subjects with AVH and in healthy controls without AVH. Positive FTD, however, was significantly higher in both groups experiencing AVH than in controls without AVH. Severity of positive FTD did not differ significantly between non-clinical subjects with AVH and schizophrenia patients with AVH.
Negative FTD (alogia) appears not to be associated with AVH. However, the fact that positive FTD (disorganised speech) in schizophrenia patients with AVH is equally high in non-clinical subjects with AVH indicates that these two symptoms tend to co-occur, which may be suggestive of a shared neurobiological substrate.

0 0
 · 
0 Bookmarks
 · 
40 Views

Keywords

40 non-clinical subjects
 
40 schizophrenia patients
 
50 healthy subjects
 
Auditory verbal hallucinations
 
AVH
 
disorganised speech
 
DSM-IV criteria
 
FTD
 
healthy controls
 
Language Index
 
language system
 
Negative FTD
 
non-clinical subjects
 
positive FTD
 
presence/absence
 
Recorded speech samples
 
schizophrenia patients
 
shared neurobiological basis
 
shared neurobiological substrate
 
two symptoms